Evidence map›Paper›PMID 38182620›Full record

ArticleNature communications2024

The virulence regulator VirB from Shigella flexneri uses a CTP-dependent switch mechanism to activate gene expression.

Sara Jakob, Wieland Steinchen, Juri Hanßmann, Julia Rosum, Katja Langenfeld, Manuel Osorio-Valeriano, Niklas Steube, Pietro I Giammarinaro, Georg K A Hochberg, Timo Glatter and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
9.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Novel Angiotensin-Converting Enzyme Inhibitory Peptides fromPharmaceuticals (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Expanding the diversity of bacterial DNA partitioning: A CTP-independent ParABProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Sara JakobDepartment of Biology, University of Marburg, Marburg, Germany.
Wieland SteinchenDepartment of Chemistry, University of Marburg, Marburg, Germany.
Juri HanßmannDepartment of Biology, University of Marburg, Marburg, Germany.ORCID 0000-0001-5816-0742
Julia RosumDepartment of Biology, University of Marburg, Marburg, Germany.
Katja LangenfeldDepartment of Ecophysiology, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID 0000-0001-9144-3250
Manuel Osorio-ValerianoDepartment of Biology, University of Marburg, Marburg, Germany.
Niklas SteubeEvolutionary Biochemistry Group, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID 0000-0001-7661-1893
Pietro I GiammarinaroDepartment of Chemistry, University of Marburg, Marburg, Germany.
Georg K A HochbergDepartment of Chemistry, University of Marburg, Marburg, Germany.ORCID 0000-0002-7155-0451
Timo GlatterMass Spectrometry and Proteomics Facility, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID 0000-0001-8716-8516
Gert BangeDepartment of Chemistry, University of Marburg, Marburg, Germany.ORCID 0000-0002-7826-0932
Andreas DiepoldDepartment of Ecophysiology, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.ORCID 0000-0002-4475-3923
Martin ThanbichlerDepartment of Biology, University of Marburg, Marburg, Germany. thanbichler@uni-marburg.de.ORCID 0000-0002-1303-1442
Philipps University of Marburg · DEMax Planck Institute for Terrestrial Microbiology · DEHarvard University · US

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) project 881 324652314EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) Grant agreement 101097986 - C-SWITCHMax-Planck-Gesellschaft (Max Planck Society) Core fundingMax-Planck-Gesellschaft (Max Planck Society) Max Planck FellowshipPhilipps-Universität Marburg (University of Marburg) core funding
6 · The paper itself

Abstract

The transcriptional antisilencer VirB acts as a master regulator of virulence gene expression in the human pathogen Shigella flexneri. It binds DNA sequences (virS) upstream of VirB-dependent promoters and counteracts their silencing by the nucleoid-organizing protein H-NS. However, its precise mode of action remains unclear. Notably, VirB is not a classical transcription factor but related to ParB-type DNA-partitioning proteins, which have recently been recognized as DNA-sliding clamps using CTP binding and hydrolysis to control their DNA entry gate. Here, we show that VirB binds CTP, embraces DNA in a clamp-like fashion upon its CTP-dependent loading at virS sites and slides laterally on DNA after clamp closure. Mutations that prevent CTP-binding block VirB loading in vitro and abolish the formation of VirB nucleoprotein complexes as well as virulence gene expression in vivo. Thus, VirB represents a CTP-dependent molecular switch that uses a loading-and-sliding mechanism to control transcription during bacterial pathogenesis.

Indexed as

DNAShigella flexneriGene ExpressionHumansHydrolysisVirulenceDNA

Identifiers

PMID38182620
PMCPMC10770331
OpenAlexW4390607567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.